These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 114683

  • 1. [Effect of combination of hetacillin, cephapirin and amikacin (author's transl)].
    Takahashi M, Ichiman Y, Usui Y, Narikawa S, Yoshida K.
    Jpn J Antibiot; 1979 Aug; 32(8):830-8. PubMed ID: 114683
    [Abstract] [Full Text] [Related]

  • 2. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM, Stille W.
    Arzneimittelforschung; 1978 Aug; 28(9):1539-41. PubMed ID: 383106
    [Abstract] [Full Text] [Related]

  • 3. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
    Mitsuhashi S, Yaginuma S, Ono H, Kurashige S.
    Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466
    [No Abstract] [Full Text] [Related]

  • 4. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD, Steffens A, Langmaack H.
    Chemotherapy; 1979 Apr; 25(5):282-5. PubMed ID: 113178
    [Abstract] [Full Text] [Related]

  • 5. [Drug sensitivity of bacteria isolated from clinical samples (author's transl)].
    Sawatari K, Mochida C, Iori F, Hayashi A, Nasu M.
    Jpn J Antibiot; 1980 Jan; 33(1):87-96. PubMed ID: 6990050
    [No Abstract] [Full Text] [Related]

  • 6. [New cephalosporin antibiotic: cephapirin].
    Urbinati G.
    Clin Ter; 1977 Mar 15; 80(5):491-9. PubMed ID: 322931
    [No Abstract] [Full Text] [Related]

  • 7. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM, Gebicka K, Borowski J.
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar 15; 17(2):129-40. PubMed ID: 4199760
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N, Oguri T.
    Jpn J Antibiot; 1975 Aug 15; 28(4):530-7. PubMed ID: 240047
    [Abstract] [Full Text] [Related]

  • 9. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    Lagast H, Pascual-Lopez A, Dejace P, Klastersky J.
    Eur J Clin Microbiol; 1986 Feb 15; 5(1):98-102. PubMed ID: 3084248
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of cephalosporins.
    Stewart D, Bodey GP.
    J Antibiot (Tokyo); 1976 Feb 15; 29(2):181-6. PubMed ID: 6411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M, Garner C, Wilcox C, Sabath LD.
    J Infect Dis; 1976 Aug 15; 134 Suppl():S75-96. PubMed ID: 823280
    [Abstract] [Full Text] [Related]

  • 18. [Antibacterial activity of a new semisynthetic aminoglycoside antibiotic amikacin (BB-K8) (author's transl)].
    Mitsuhashi S, Kawabe H, Iyobe S, Tanaka T, Inoue M.
    Jpn J Antibiot; 1974 Apr 15; 27(2):189-92. PubMed ID: 4211300
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL, Provonchee RB, Glicksman C, Zinner SH.
    Antimicrob Agents Chemother; 1977 Sep 15; 12(3):349-52. PubMed ID: 410362
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.